[1]
Becerra Zúñiga, P. et al. 2019. Systematic review of quadrivalent vs. nonavalent vaccine as a prophylactic treatment for cervical cancer caused by human papillomavirus (HPV). Lux Médica. 14, 42 (Nov. 2019), 37–47. DOI:https://doi.org/10.33064/42lm20192246.